Evofem Biosciences, Inc.

OTC:EVFM

0.07 (USD) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q4
Revenue 4.163.6034.8395.1122.4585.8090.1816.3716.0344.2513.571.7121.8571.1050.1680.278000000000000000000000000000
Cost of Revenue 0.8110.7431.0211.8892.2931.3760.3841.681.2851.0661.7550.9550.8390.5060.1510.317000000000000000000000000000
Gross Profit 3.3492.863.8183.2230.1654.433-0.2034.6914.7493.1851.8150.7571.0180.5990.017-0.039000000000000000000000000000
Gross Profit Ratio 0.8050.7940.7890.630.0670.763-1.1220.7360.7870.7490.5080.4420.5480.5420.101-0.14000000000000000000000000000
Reseach & Development Expenses 0.2630.5821.3610.6140.4020.541.695.2077.74410.3918.6598.7018.5077.2625.9464.2172.644.2473.4325.6635.2467.8899.7729.85111.83311.9590.3530.4871.5561.550.9250.9651.4283.267.02815.2117.474.7011.9170.9430.9321.3831.712
General & Administrative Expenses 2.2672.8243.2543.1764.9023.6183.1596.269.1269.0185.6524.9576.4167.6846.0087.29.7357.1429.448.6346.6955.7435.2098.58211.4099.0272.0181.3331.2721.4761.0560.9051.0922.5212.2041.7691.7291.9371.3410.9231.0511.1020.826
Selling & Marketing Expenses 2.2432.3452.6282.9852.1973.854711.94812.29812.70524.92230.46827.23730.52523.91414.79.9977.8553.983.7531.2931.097000000000000000000000
SG&A 4.4755.1225.8376.1617.0997.47210.15918.20821.42421.72330.57435.42533.65338.20929.92221.919.73214.9979.448.6346.6955.7435.2098.58211.4099.0272.0181.3331.2721.4761.0560.9051.0922.5212.2041.7691.7291.9371.3410.9231.0511.1020.826
Other Expenses -0.558-3.891-0.587-0.596-1.127-0.318-0.765-0.436-0.415-0.471-1.211-1.19-1.186-1.145-1.072-0.657-0.349-0.0040.0350.287-20.298-0.014-0.03-0.033-0.032-0.0500000000000000000
Operating Expenses 4.7385.7047.1986.7757.5018.01211.84923.41529.16832.11439.23344.12642.1645.47135.86826.11722.37219.24412.87214.29711.94113.63214.98118.43323.24220.9862.3711.822.8283.0261.9811.872.525.7819.23216.989.1996.6383.2581.8661.9832.4852.538
Operating Income -1.389-2.844-3.38-3.552-7.336-3.579-12.052-18.724-24.419-28.929-37.418-43.369-41.142-44.872-35.851-26.156-22.372-19.244-12.872-14.297-11.941-13.632-14.981-18.433-23.242-20.986-2.371-1.82-2.828-3.026-1.981-1.87-2.52-5.781-9.232-16.98-9.199-6.638-3.258-1.866-1.983-2.485-2.538
Operating Income Ratio -0.334-0.789-0.698-0.695-2.985-0.616-66.586-2.939-4.047-6.805-10.481-25.332-22.155-40.608-213.399-94.086000000000000000000000000000
Total Other Income Expenses Net 2.748-1.9651.26669.566-1.2271.2283.724108.243-101.545-2.956-14.131-30.6957.724-1.287-4.762-3.762-30.323-0.0040.0350.287-23.613-4.454-0.03-0.033-0.032-48.10.0110.0130.0140.0130.009-0.492-0.138-0.245-0.283-0.282-0.278-0.2640.569-2.044-0.2710.886-0.245
Income Before Tax 1.359-4.809-2.11466.016-8.555-2.351-8.32889.519-125.96-31.885-51.548-74.061-33.414-46.152-40.596-29.897-52.666-19.146-12.717-13.798-35.446-18.068-14.981-18.431-23.242-69.056-2.36-1.806-2.814-3.014-1.972-2.362-2.657-6.027-9.515-17.262-9.477-6.902-2.897-4.041-2.279-1.602-2.791
Income Before Tax Ratio 0.327-1.335-0.43712.914-3.48-0.405-46.01114.051-20.875-7.501-14.439-43.26-17.994-41.767-241.643-107.543000000000000000000000000000
Income Tax Expense 0.0080.0160.0230.0110.0030.0030.0080.0130.020.0030.00629.5020.012-0.0010.0020.00229.945-0.102-0.185-0.2780.0044.422-0.096-0.0350.0020.0660.0110.0130.0140.013-0.0060.0140.0160.02-0.0120.006-0.0120.0070.2070.1320.0260.0040.008
Net Income 1.351-4.809-2.11466.005-8.558-2.354-8.33689.506-125.98-31.888-51.554-74.061-33.426-46.151-40.598-29.899-52.666-19.146-12.717-13.798-35.45-18.068-14.981-18.431-23.244-69.056-2.36-1.806-2.814-3.014-1.972-2.362-2.657-6.027-9.515-17.262-9.477-6.902-2.897-4.041-2.279-1.602-2.791
Net Income Ratio 0.325-1.335-0.43712.912-3.482-0.405-46.05514.049-20.878-7.501-14.441-43.26-18-41.766-241.655-107.55000000000000000000000000000
EPS 0.02-0.15-0.1115.34-5.42-1.85-8.51135.72-580.48-354.31-572.82-925.76-477.51-1,153.78-1,014.95-747.47-1,755.53-744.86-504.42-562.52-1,809.6-1,260.15-1,087.94-1,340.63-2,088.6-8,647.13-2,258.16-1,728.49-2,692.6-2,883.86-12.83-1,923.84-2,167.61-4,931.72-62.35-14,184.13-7,800.35-5,680.97-40.35-3,427.36-1,933.39-1,358.98-1.96
EPS Diluted -0.001-0.15-0.110.1-5.42-1.85-8.51-4.39-580.48-354.31-572.82-925.76-477.51-1,153.78-1,014.95-747.47-1,755.53-744.86-502.59-559.51-1,809.6-1,260.15-1,087.94-1,340.63-2,088.6-8,647.13-2,258.16-1,728.49-2,692.6-2,883.86-12.83-1,923.84-2,167.61-4,931.72-62.35-14,184.13-7,800.35-5,680.97-40.35-3,427.36-1,933.39-1,358.98-1.96
EBITDA -1.347-2.785-3.313-73.677-7.063-4.862-16.261-127.10376.961-26.178-24.498-13.596-49.777-44.535-32.161-22.9937.656-19.175-12.872-14.297-8.626-9.126-14.981-18.368-23.17627.129-2.34-1.799-2.807-3.002-1.972-1.838-2.486-5.744-9.226-16.956-9.192-6.627-3.253-1.86-1.978-2.479-2.532
EBITDA Ratio -0.324-0.773-0.685-14.413-2.873-0.837-89.84-19.9512.755-6.158-6.862-7.942-26.805-40.303-191.435-82.709000000000000000000000000000